MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0091595
Molecular Synthesis Private Limited
Molecular Synthesis Private Limited - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹73.22 Lakh
▲ 274% YoY
Net loss · FY 2025
₹12.74 Lakh
Net margin -17.4%
EBITDA · FY 2025
₹1.11 Lakh
EBITDA margin 1.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹12.94 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Molecular Synthesis Private Limited
Data last updated:
Molecular Synthesis Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 31 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC336949.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kunal Satyen Daga (Managing Director) and Kokila Amrutlal Gadhiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101 1st Floor Mahek Plaza Maharashtra Nagar Borivali West, Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.22 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹12.74 Lakh (net margin -17.4%) and EBITDA of ₹1.11 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
The company is associated with 1 brand: Molsynth. As per MCA filings, the company has open charges of ₹12.94 Lakh on record.
Molecular Synthesis Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0091595).
Company details
CIN U24290MH2020PTC336949
Registration Number 336949
Incorporation Date 31 January 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0091595
Recognitions & Rankings of Molecular Synthesis
Contact details
Molecular Synthesis Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address101 1st Floor Mahek Plaza Maharashtra Nagar Borivali West, Mumbai, Maharashtra, India – 400092
- IndustryChemicals, Other Chemical Product, Manufacturing
Comprehensive company report
Molecular Synthesis Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Molecular Synthesis operates one associated brand: Molsynth. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| molsynth.co |
Business activity
The main business activity of Molecular Synthesis is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Molecular Synthesis Private Limited, buy the company report.
Financials of Molecular Synthesis Private Limited
FY 2025 filings availableMolecular Synthesis Private Limited reported revenue of ₹73.22 Lakh (up 274% YoY) for FY 2025.
Revenue · FY 2025
₹73.22 Lakh ▲ 274%
Net loss · FY 2025
₹12.74 Lakh margin -17.4%
EBITDA · FY 2025
₹1.11 Lakh margin 1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 274%
3 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 114%
3 years · compounded
▲ 27%
Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 274% growth in the latest year. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | -17.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Molecular Synthesis Private Limited, buy the company report.
Board of directors of Molecular Synthesis Private Limited
Molecular Synthesis has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kokila Amrutlal Gadhiya Also directs: Daga Global Chemicals Private Limited, Niranjan Organics Private Limited, Daga Specialities Private Limited and 1 more | Director | 31 Jan 2020 | 6 Years 8 Months | Current |
| Kunal Satyen Daga Also directs: Daga Global Chemicals Private Limited, San Marine LLP | Managing Director | 31 Jan 2020 | 6 Years 8 Months | Current |
Peer comparison
Molecular Synthesis Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asma Chemicals Limited | ₹75.21 Lakh (FY 2024) | -67.0% | Uttar Pradesh, India | |||
| Saline Salt Private Limited | ₹74.2 Lakh (FY 2024) | -67.0% | Antarjal, Gujarat, India | |||
| Molecular Synthesis Private Limitedthis company | ₹73.22 Lakh (FY 2025) | -₹12.74 Lakh | -17.4% | 274.0% | Mumbai, Maharashtra, India | |
| Ecosterile Marketing Private Limited | ₹70.5 Lakh (FY 2025) | 24.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Molecular Synthesis Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12.94 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Dec 2020 | 100418834 | Hdfc Bank Limited | ₹12.94 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Molecular Synthesis Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Molecular Synthesis Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Molecular Synthesis Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Molecular Synthesis Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Kunal Satyen Daga ceased to be Director on 09 Mar 2025.
AGM
Molecular Synthesis Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Molecular Synthesis Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Kunal Satyen Daga ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.94 Lakh with Charge ID 100418834 was registered on 01 Dec 2020.
Appointed
Kokila Amrutlal Gadhiya was appointed as Director.
Appointed
Kunal Satyen Daga was appointed as Managing Director.
Incorporation
31 Jan 2020
Molecular Synthesis Private Limited was registered on 31 Jan 2020 with Roc Mumbai I & aged 6 years 8 months as per MCA records.
Frequently asked questions
Molecular Synthesis is an active private limited company based in Mumbai, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 31 January 2020 (6+ years old) and is registered under CIN U24290MH2020PTC336949.
Molecular Synthesis has 2 current directors:
- Kunal Satyen Daga - Managing Director
- Kokila Amrutlal Gadhiya - Director
The latest financial statements of Molecular Synthesis on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Molecular Synthesis is U24290MH2020PTC336949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Molecular Synthesis was incorporated on 31 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Molecular Synthesis by revenue are Asma Chemicals Limited, Saline Salt Private Limited, Ecosterile Marketing Private Limited, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kunal Satyen Daga ceased to be Director on 09 Mar 2025. Kokila Amrutlal Gadhiya was appointed as Director on 31 Jan 2020. Kunal Satyen Daga was appointed as Managing Director on 31 Jan 2020.
Yes, Molecular Synthesis is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0091595).
The registered office of Molecular Synthesis is at 101 1st Floor Mahek Plaza Maharashtra Nagar Borivali West, Mumbai, Maharashtra, India – 400092.
Molecular Synthesis operates in the chemicals industry, in the other chemical product segment.
Molecular Synthesis has open charges of ₹12.94 Lakh and no satisfied charges on record as per latest MCA filings.